Samsung Biologics Co.,Ltd.
Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 207940.KS | 068270.KS | TECH | MENS | DNA | SCNI | |
|---|---|---|---|---|---|---|
| Market cap | 60.43T | 44.24T | 11.38B | 139.89M | 691.58M | 1.02M |
| P/E (TTM) | — | — | 62.6 | — | — | 0.0 |
| Forward P/E | — | — | 31.4 | — | -3.5 | — |
| Price/book | — | — | 5.4 | -5.5 | 1.6 | 0.1 |
| Dividend yield | — | 0.37% | 0.44% | — | — | — |
| 1-year change | −27.39% | +15.02% | +16.04% | −96.88% | −24.65% | −93.56% |
| Today | +4.09% | +6.53% | +0.07% | −7.07% | −12.67% | −16.54% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All 207940.KS news ›Court Limits Samsung Biologics Strike, Expanding Protected Processes to Nine
Union Faces 20 Million Won Penalty Per Violation Union Reconsiders Plan for Second General Strike on the 26th A court has curbed a second general strike planned by the labor union at Samsung Biologics (207940), accepting the company's…
Appeals court broadens Samsung Biologics strike ban, curbs union leverage in Korea
Appeals judges side with management, classifying early bioprocess steps as security work and narrowing strike impact The likelihood that Samsung Biologics(207940), a CDMO in biopharmaceuticals, will face production disruptions due to a…
Samsung Biologics Union Plans Rally, Three-Week Strike
Union Notifies Authorities of 2,000-Person Gathering as It Escalates Collective Action Labor and Management Remain Apart on Base Pay and Performance Bonuses Company Says It Will Keep Dialogue Open and Ensure Stable Operations The labor…
Samsung Biologics Union to Hold Group Action on Oct. 21 Ahead of Second General Strike
▲ Flags flutter in the wind at the Samsung Biologics plant in Yeonsu-gu, Incheon, on the morning of May 1, the first day of the labor union's general strike. The labor union of Samsung Biologics is set to launch a group action on October…
Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
TradingView Polypeptide Group Definitive Interim Result Of The Public Tender Offer Of Samsung Biologics
Korea Investment & Securities lifts Samsung Biologics target on resilient CMO demand
Korea Investment & Securities Co. maintained a "buy (BUY)" rating and raised its target price to 1.95 million won for Samsung Biologics(207940), saying medium- to long-term growth remains intact despite a rights offering and a strike that…
Labor Dispute Is Key Variable for Samsung Biologics by End of This Month
Third-Quarter Results Seen in Line With Consensus May Walkout Cost About 150 Billion Won in Revenue Three-Week Strike Could Hit First Quarter of Next Year Samsung Biologics (207940) is expected to post third-quarter results in line with…
Samsung Biologics Clears Tender Offer Threshold for PolyPeptide Group
Preliminary Interim Results Show 87.88% Tendered, Above 66.7% Minimum Deal to Close by End-November After Regulatory Approvals, Opening Peptide Push Samsung Biologics (207940.KS) has cleared the minimum acceptance threshold in its tender…
Samsung Biologics secures 88% in Polypeptide bid, targets November close
Tender take-up tops threshold as Samsung Biologics eyes peptide CDMO expansion and November finish Samsung Biologics(207940) secured 87.88% of the shares targeted in the tender offer to acquire Swiss peptide contract development and…
Samsung Biologics union sets three-week strike as talks collapse
Aju Press Samsung Biologics union sets three-week strike as talks collapse China Warns France and Germany Against EU Trade Measures Targeting Beijing AI to Automate Toxicity Data Collection for Chemical Risk Assessments Busan Mascot…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
biz.chosun.com9
-
en.sedaily.com8
-
asiae.co.kr6
-
businesskorea.co.kr3
-
finance.biggo.com3
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 42 articles, not a forecast.